Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences

Serena Nik-Zainal; Helen Davies; Johan Staaf; Manasa Ramakrishna; Dominik Glodzik; Xueqing Zou; Inigo Martincorena; Ludmil B Alexandrov; Sancha Martin; David C Wedge; Peter Van Loo; Young Seok Ju; Marcel Smid; Arie B Brinkman; Sandro Morganella; Miriam R Aure; Ole Christian Lingjærde; Anita Langerød; Markus Ringnér; Sung-Min Ahn; Sandrine Boyault; Jane E Brock; Annegien Broeks; Adam Butler; Christine Desmedt; Luc Dirix; Serge Dronov; Aquila Fatima; John A Foekens; Moritz Gerstung; Gerrit K J Hooijer; Se Jin Jang; David R Jones; Hyung-Yong Kim; Tari A King; Savitri Krishnamurthy; Hee Jin Lee; Jeong-Yeon Lee; Yilong Li; Stuart McLaren; Andrew Menzies; Ville Mustonen; Sarah O'Meara; Iris Pauporté; Xavier Pivot; Colin A Purdie; Keiran Raine; Kamna Ramakrishnan; F Germán Rodríguez-González; Gilles Romieu; Anieta M Sieuwerts; Peter T Simpson; Rebecca Shepherd; Lucy Stebbings; Olafur A Stefansson; Jon Teague; Stefania Tommasi; Isabelle Treilleux; Gert G Van den Eynden; Peter Vermeulen; Anne Vincent-Salomon; Lucy Yates; Carlos Caldas; Laura Van't Veer; Andrew Tutt; Stian Knappskog; Benita Kiat Tee Tan; Jos Jonkers; Åke Borg; Naoto T Ueno; Christos Sotiriou; Alain Viari; P Andrew Futreal; Peter J Campbell; Paul N Span; Steven Van Laere; Sunil R Lakhani; Jorunn E Eyfjord; Alastair M Thompson; Ewan Birney; Hendrik G Stunnenberg; Marc J van de Vijver; John W M Martens; Anne-Lise Børresen-Dale; Andrea L Richardson; Gu Kong; Gilles Thomas; Michael R Stratton

doi:10.1038/s41586-019-0883-2

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences

Nature. 2019 Feb;566(7742):E1. doi: 10.1038/s41586-019-0883-2.

Authors

Serena Nik-Zainal^{1

2}, Helen Davies³, Johan Staaf⁴, Manasa Ramakrishna³, Dominik Glodzik³, Xueqing Zou³, Inigo Martincorena³, Ludmil B Alexandrov^{3

5

6}, Sancha Martin³, David C Wedge³, Peter Van Loo^{3

7}, Young Seok Ju³, Marcel Smid⁸, Arie B Brinkman⁹, Sandro Morganella¹⁰, Miriam R Aure^{11

12}, Ole Christian Lingjærde^{12

13}, Anita Langerød^{11

12}, Markus Ringnér⁴, Sung-Min Ahn¹⁴, Sandrine Boyault¹⁵, Jane E Brock¹⁶, Annegien Broeks¹⁷, Adam Butler³, Christine Desmedt¹⁸, Luc Dirix¹⁹, Serge Dronov³, Aquila Fatima²⁰, John A Foekens⁸, Moritz Gerstung³, Gerrit K J Hooijer²¹, Se Jin Jang²², David R Jones³, Hyung-Yong Kim²³, Tari A King²⁴, Savitri Krishnamurthy²⁵, Hee Jin Lee²², Jeong-Yeon Lee²⁶, Yilong Li³, Stuart McLaren³, Andrew Menzies³, Ville Mustonen³, Sarah O'Meara³, Iris Pauporté²⁷, Xavier Pivot²⁸, Colin A Purdie²⁹, Keiran Raine³, Kamna Ramakrishnan³, F Germán Rodríguez-González⁸, Gilles Romieu³⁰, Anieta M Sieuwerts⁸, Peter T Simpson³¹, Rebecca Shepherd³, Lucy Stebbings³, Olafur A Stefansson³², Jon Teague³, Stefania Tommasi³³, Isabelle Treilleux³⁴, Gert G Van den Eynden^{19

35}, Peter Vermeulen^{19

35}, Anne Vincent-Salomon³⁶, Lucy Yates³, Carlos Caldas³⁷, Laura Van't Veer¹⁷, Andrew Tutt^{38

39}, Stian Knappskog^{40

41}, Benita Kiat Tee Tan^{42

43}, Jos Jonkers¹⁷, Åke Borg⁴, Naoto T Ueno²⁵, Christos Sotiriou¹⁸, Alain Viari^{44

45}, P Andrew Futreal^{3

46}, Peter J Campbell³, Paul N Span⁴⁷, Steven Van Laere¹⁹, Sunil R Lakhani^{31

48}, Jorunn E Eyfjord³², Alastair M Thompson^{29

49}, Ewan Birney¹⁰, Hendrik G Stunnenberg⁹, Marc J van de Vijver²¹, John W M Martens⁸, Anne-Lise Børresen-Dale^{11

12}, Andrea L Richardson^{16

20}, Gu Kong⁵⁰, Gilles Thomas⁵¹, Michael R Stratton⁵²

Affiliations

¹ Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK. snz@sanger.ac.uk.
² East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 9NB, UK. snz@sanger.ac.uk.
³ Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
⁴ Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, SE-223 81, Sweden.
⁵ Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, New Mexico, USA.
⁶ Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico, 87545, USA.
⁷ Department of Human Genetics, University of Leuven, B-3000, Leuven, Belgium.
⁸ Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, 3015CN, The Netherlands.
⁹ Radboud University, Department of Molecular Biology, Faculty of Science, 6525GA, Nijmegen, The Netherlands.
¹⁰ European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, UK.
¹¹ Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, 0310, Norway.
¹² K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, 0310, Norway.
¹³ Department of Computer Science, University of Oslo, Oslo, Norway.
¹⁴ Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon, South Korea.
¹⁵ Translational Research Lab, Centre Léon Bérard, 28, rue Laënnec, 69373, Lyon Cedex 08, France.
¹⁶ Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, 02115, USA.
¹⁷ The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
¹⁸ Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000, Brussels, Belgium.
¹⁹ Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
²⁰ Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, USA.
²¹ Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
²² Department of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea.
²³ Department of Pathology, College of Medicine, Hanyang University, Seoul, 133-791, South Korea.
²⁴ Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10065, USA.
²⁵ Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard., Houston, Texas, 77030, USA.
²⁶ Institute for Bioengineering and Biopharmaceutical Research (IBBR), Hanyang University, Seoul, South Korea.
²⁷ Institut National du Cancer, Research Division, Clinical Research Department, 52 avenue Morizet, 92513, Boulogne-Billancourt, France.
²⁸ University Hospital of Minjoz, INSERM UMR 1098, Bd Fleming, Besançon, 25000, France.
²⁹ Pathology Department, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK.
³⁰ Oncologie Sénologie, ICM Institut Régional du Cancer, Montpellier, France.
³¹ The University of Queensland, UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland, 4029, Australia.
³² Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101, Reykjavik, Iceland.
³³ IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
³⁴ Department of Pathology, Centre Léon Bérard, 28 rue Laënnec, 69373, Lyon Cédex 08, France.
³⁵ Department of Pathology, GZA Hospitals Sint-Augustinus, Antwerp, Belgium.
³⁶ Institut Curie, Paris Sciences Lettres University, Department of Pathology and INSERM U934, 26 rue d'Ulm, 75248, Paris Cedex 05, France.
³⁷ Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.
³⁸ Breast Cancer Now Research Unit, King's College London, London, SE1 9RT, UK.
³⁹ Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, SW3 6JB, UK.
⁴⁰ Department of Clinical Science, University of Bergen, 5020, Bergen, Norway.
⁴¹ Department of Oncology, Haukeland University Hospital, 5021, Bergen, Norway.
⁴² National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore, Singapore.
⁴³ Singapore General Hospital, Outram Road, 169608, Singapore, Singapore.
⁴⁴ Equipe Erable, INRIA Grenoble-Rhône-Alpes, 655, Avenue de l'Europe, 38330, Montbonnot-Saint Martin, France. Alain.Viari@inria.fr.
⁴⁵ Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France. Alain.Viari@inria.fr.
⁴⁶ Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, Texas, 77230, USA.
⁴⁷ Department of Radiation Oncology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, 6525GA, The Netherlands.
⁴⁸ Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia.
⁴⁹ Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, Texas, 77030, USA.
⁵⁰ Department of Pathology, College of Medicine, Hanyang University, Seoul, 133-791, South Korea. gkong@hanyang.ac.kr.
⁵¹ Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France.
⁵² Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK. mrs@sanger.ac.uk.

PMID: 30659290
DOI: 10.1038/s41586-019-0883-2

Abstract

In the Methods section of this Article, 'greater than' should have been 'less than' in the sentence 'Putative regions of clustered rearrangements were identified as having an average inter-rearrangement distance that was at least 10 times greater than the whole-genome average for the individual sample. '. The Article has not been corrected.

Publication types

Published Erratum